MedPath

Internet-delivered Emotion Regulation Individual Therapy for Adolescents With NSSI - An Open Pilot Study

Not Applicable
Completed
Conditions
Nonsuicidal Self-Injury
Interventions
Behavioral: Internet-delivered Emotion Regulation Individual Therapy for Adolescents
Registration Number
NCT02697019
Lead Sponsor
Karolinska Institutet
Brief Summary

The primary aim is to investigate the effectiveness of an Internet-delivered Emotion Regulation Individual Therapy for Adolescents (ERITA) with nonsuicidal self-injury (NSSI).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria

A primary diagnosis of NSSI as defined in Section 3 in the fifth edition of the Diagnostic and Statistical Manual 5 of the American Psychiatric Association (DSM-5) < 1 NSSI episode during the past month At least one parent needs to commit to participate in the parent program

Read More
Exclusion Criteria

Bipolar disorder I or primary psychosis Severe suicidal ideation Ongoing substance dependence Insertion/withdrawal of psychopharmacological substances within two months prior to the treatment Other acute primary axis I diagnosis (e.g. anorexia nervosa) that demand treatment in first hand Current life circumstances that would hinder the treatment (i.e. ongoing domestic abuse) insufficient Swedish language skills Cocurrent treatment with Mentalization based therapy (MBT) or Dialectical behavioral therapy (DBT)

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Internet-delivered ERITAInternet-delivered Emotion Regulation Individual Therapy for Adolescents-
Primary Outcome Measures
NameTimeMethod
Deliberate Self-Harm Inventory - 9 item versionBaseline (30 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks), and three and six months follow-up

Change from baseline in self-harming behaviors when measures weekly, after 12 weeks, and at 3 and 6 months after treatment has ended

Secondary Outcome Measures
NameTimeMethod
Acceptance and Action Questionnaire (AAQ-7)Baseline (7 days prior to treatment start), post-treatment (12 weeks), three and six months follow-up]

Change from baseline in acceptance and action after 12 weeks, at 3 and 6 months after treatment has ended

The Revised Child Anxiety and Depression Scale - Child and Parent rated (RCADS-C)Baseline (7 days prior to treatment start), post-treatment (12 weeks), three and six months follow-up]

Change from baseline in anxiety and depression after 12 weeks, at 3 and 6 months after treatment has ended

Borderline Symptom List Behavior supplement (BSL-supplement)Baseline (30 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks), and three and six months follow-up

Change from baseline in self-destructive behaviors when measures weekly, after 12 weeks, and at 3 and 6 months after treatment has ended

Difficulties in Emotion Regulation Scale -16 item version (DERS-16)Baseline (30 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks), and three and six months follow-up

Change from baseline in difficulties in emotion regulation when measures weekly, after 12 weeks, and at 3 and 6 months after treatment has ended

Difficulties in Emotion Regulation Scale (DERS)Baseline (7 days prior to treatment start), post-treatment (12 weeks), three and six months follow-up]

Change from baseline in difficulties in emotion regulation after 12 weeks, at 3 and 6 months after treatment has ended

Borderline personality features in childhood (BPFS-C)Baseline (7 days prior to treatment start), post-treatment (12 weeks), three and six months follow-up]

Change from baseline in symptoms of borderline personality disorder after 12 weeks, at 3 and 6 months after treatment has ended

Suicidal Ideation Questionnaire (SIQ-JR)Baseline (7 days prior to treatment start), post-treatment (12 weeks), three and six months follow-up]

Change from baseline in suicidal ideation after 12 weeks, at 3 and 6 months after treatment has ended

Trial Locations

Locations (1)

Karolinska Institutet

🇸🇪

Stockholm, Sweden

© Copyright 2025. All Rights Reserved by MedPath